Ernexa Therapeutics Inc. (ERNA)
NASDAQ: ERNA · Real-Time Price · USD
1.320
+0.010 (0.76%)
At close: Dec 5, 2025, 4:00 PM EST
1.298
-0.022 (-1.66%)
After-hours: Dec 5, 2025, 7:47 PM EST
Ernexa Therapeutics Market Cap
Ernexa Therapeutics has a market cap or net worth of $10.36 million as of December 5, 2025. Its market cap has decreased by -70.65% in one year.
Market Cap
10.36M
Enterprise Value
7.87M
1-Year Change
-70.65%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since March 26, 2021, Ernexa Therapeutics's market cap has decreased from $197.28M to $10.36M, a decrease of -94.75%. That is a compound annual growth rate of -46.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 10.28M | -31.93% |
| Dec 31, 2024 | 15.10M | 55.53% |
| Dec 29, 2023 | 9.71M | -41.17% |
| Dec 30, 2022 | 16.51M | -92.39% |
| Dec 31, 2021 | 217.02M | 10.01% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |